This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Ibuprofen is a type of nonsteroidal anti-inflammatory drug ( NSAID ) that is used to treat various inflammatory conditions. Its available both as an over-the-counter (OTC) drug and by prescription. As an OTC medication, ibuprofen is approved by the Food and Drug Administration (FDA) to treat fever, pain, menstrual cramps, headaches, migraines, sore throats, cold and flu symptoms, joint pain and stiffness, and dental pain.
President Trump signaled his intention to withdraw from the World Health Organization on Monday, a move global health experts fear will both cripple the agency and substantially weaken international health security — in the United States and abroad. A U.S. withdrawal from the WHO would deprive the Geneva-based institution of its biggest funder and a major contributor of scientific expertise, likely necessitating a massive reorganization and a curtailment of the functions the WHO is a
Around 65% of adults in the United States say willpower alone is not enough to lose weight and keep it off with lifestyle changes, according to a Pew Research survey from 2024. That means there are millions of people looking to weight loss drugs for help. One such drug is phentermine (brand name: Adipex ). If youre taking Wellbutrin (bupropion) for depression and are considering weight loss medication, you may wonder whether phentermine is safe.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Losing weight can be tough. And it can be even tougher for people who have Type 2 diabetes, which can impair weight loss. Thats why it might seem natural to treat both obesity and diabetes simultaneously. For the past half-century, phentermine has been one of the most commonly prescribed weight loss drugs, and metformin has been one of the most popular diabetes medicationsand its also prescribed off-label for weight reduction.
Jonathan Watanabe, PharmD, MS, PhD, BCGP, discussed a section of the ASHP 2025 Pharmacy Forecast that he co-authored titled Addressing the Gap in Primary Care.
Though it was dismissed from an antitrust lawsuit last year, the threat of a second administrative case pushed the private equity firm toward a settlement. Though the agency and its chair celebrated the deal as a victory over private equity, the firm and the agency's upcoming head suggested political posturing.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Though it was dismissed from an antitrust lawsuit last year, the threat of a second administrative case pushed the private equity firm toward a settlement. Though the agency and its chair celebrated the deal as a victory over private equity, the firm and the agency's upcoming head suggested political posturing.
The authors found that humidity, cold and heat waves, and air pollution led to a higher likelihood of asthma- and chronic obstructive pulmonary disease (COPD)-related hospitalizations.
U.S. District Judge Matthew Kacsmaryk ruled Thursday that Idaho, Kansas and Missouri may move forward on a challenge to the regulatory clearance of mifepristone.
The reduction in cardiovascular end points and the increase in adverse events observed in a clinical trial were largely transportable to trial-eligible chronic kidney disease (CKD) populations from clinical practice.
GE Healthcare struck a seven-year agreement with Sacramento, California-based Sutter Health to provide AI-powered medical imaging technology and digital solutions. The health system's work with GE Healthcare also supports Sutters larger access strategy, as the nonprofit system aims to expand its ambulatory footprint.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Justice Department alleges that Walgreens acted in violation of the Controlled Substances Act and sought reimbursement for unlawful prescriptions, violating the False Claims Act.
In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Donald Prentiss, founder and CEO, Qualthera, explains how collaboration between compounding pharmacies, drug manufacturers, and telehealth platforms can drive success, despite the various litigations pertaining to GLP-1s that currently taking place.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Panelists discuss how untreated tardive dyskinesia severely impacts patients' daily functioning and quality of life through physical limitations affecting basic tasks like eating and walking, social isolation due to visible symptoms, and heightened risks for older adults who face increased fall risks, difficulty maintaining independence, and complications from age-related comorbidities.
This week, at the J.P. Morgan Healthcare Conference and the Biotech Showcase, discussions underscored the growing focus on innovation in cell and gene therapies.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Despite challenges surrounding communication overload, drug shortages, and cybersecurity risks, this term is revolutionizing medication management and patient care through the use artificial intelligence and predictive forecasting.
Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please submit the good newsor the badfrom your shop, and we will feature it here at the end of each week.
Jennifer Clements, a clinical professor and the director of pharmacy education at the University of South Carolina, discusses the pharmacists role in diabetes care.
We ran a Q&A with John Clarke, associate director in patient recruitment at Innovaderm on the changing landscape of patient centricity in terms of clinical trials and how the industry can navigate the evolving regulatory expectations around it.
Approval is based on data from the Phase III CodeBreaK 300 trial, which demonstrated that treatment with Lumakras and Vectibix significantly improved progression-free survival in patients with KRAS G12C-mutated metastatic colorectal cancer.
AI technology, such as GenAI and ChatGPT, is set to revolutionise experiences in 2025 across various industries, including life science. Learn more about the future of AI and its impact on the way we interact and innovate.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content